Institutions participating in the Respiratory Failure Research Group in JapanŴ eprospectively examined the survival rate of 67 chronic obstructive pulmonary disease (COPD) and 74 late sequelae of pulmonary tuberculosis (TB seq) patients to clarify whether nocturnal oxyhemoglobin desaturation (NOD)could be one of the independent factors determining their mortality. The sleep monitoring of arterial oxygen saturation (SpO2) and pulmonary function tests were assessed in all patients at the time of registration. Forty % of COPDand 24%of TB seq died as the direct result of deterioration of chronic respiratory failure during the 7-year observation period. Cox's proportional hazards analysis showed that NODwas an independent prognostic factor in both groups, and this was especially prominent when evaluated in terms of sleep lowest SpO2in COPDand 85%desaturation time in TB seq. No significant prognostic factor was observed among age, vital capacity percent predicted (%VC), forced expiratory volume in one second (FEVL0%)and partial pressure of carbon dioxide (PaCO2). Weconclude that the degree of NODcan affect mortality in COPDand TB seq.
Introduction
Hypoxemiais a well-recognized poor prognostic factor, and thus is one of the indications for long-term oxygen therapy (LTOT) in respiratory failure ( 1) . The complications of nocturnal oxyhemoglobin desaturation (NOD) as well as pulmonary hypertension and exercise-induced oxyhemoglobin desaturation have also been considered as indicative findings for prescribing LTOT(2-6). However, the clinical interpretation of NOD,i.e., how to use NODin preparing guidelines for LTOT,has remained incomplete. Furthermore, it has not been determined whether NODby itself has significant influence on the mortality of patients with chronic obstructive pulmonary disease (COPD) and late sequelae of pulmonary tuberculosis (TB seq). It is conceivable that NODoccurs partly because of the deterioration of underlying pathophysiological conditions which becomemore manifest during sleep than wakefulness. It is also recognized that the underlying mechanismsresponsible for NODare different between COPDand TB seq; the former may mainly be ascribed to hypoventilation in association with the exacerbated imbalance in ventilation-perfusion ratio (7) (8) , and the latter may be mostly due to hypoventilation during sleep (6).
The purpose of this study was to elucidate whether or not NOD may be an independent prognostic factor in COPDand TB seq.
Methods
Sixty-seven patients with COPD(53 males and 14 females) and 74 with TB seq (49 males and 25 females) were pre-Nocturnal Desaturation and Prognosis registered in July 1988, and they were followed up for 7 years in 15 institutions participating in the Respiratory Failure Research Group in Japan. Anthropometric and pulmonary function data at the time of entry are shownin Table 1 . The registration form contained the information on age, sex and clinical diagnosis as determined by the attending physicians at each institution. At the start of observation, the following data were provided: the sleep monitoring of arterial oxygen saturation (SpO2) using pulse oximetry, arterial blood gases while breathing air, vital capacity percent predicted (%VC), FEV1>0 percent predicted (%FEVL0) and FEVL0/FVC (FEVL0%). Patients with sleep apnea syndromewere excluded from this study. Baseline SpO2values were obtained in the supine resting position before sleep. The degree of NODwas evaluated in two different ways; the lowest value of SpO2 observed during sleep, defined as "sleep lowest SpO2", and the total time spent with SpO2 at less than 85%, defined as "85% desaturation time". Statistical analysis All values were expressed by mean± SD. Comparison between two groups was performed by the Student's t-test. Survival rates of both groups for respiratory failure-related death were evaluated using the Kaplan-Meier method, and were compared using the log-rank test. P values <0.05 were considered significant.
Results

Pulmonary function and sleep data
There was no difference between the two groups in terms of age and partial pressure of oxygen (PaO2). FEVL0%was significantly lower in the COPDgroup, while %VCand %FEV!0 was considerably lower in the TB seq group. TB seq patients had higher PaCO2 values than the COPDpatients ( Table 1) .
Results of the sleep monitoring of SpO2are shown in Table  2 . There was no difference between the two groups in baseline SpO2. Although 85%desaturation time was not different between the two groups, the level of sleep lowest SpO2 was more profound in the TB seq than in the COPDgroup (p<0.001).
Survival rate Among the 67 COPD patients, 37 (55%) died during the observation period, 27 (40%) could be followed up for the duration of the observation period, and 3 (5%) were lost to follow-up. The mean follow-up period was 48.5 ± 24.8 months (5.0-84.0 months). Fifty-one COPD patients (76%) received LTOTduring the observation period. The causes of death for the COPDgroup were exacerbation of respiratory failure and related diseases such as right heart failure, pneumonia and pneumothorax (27 patients; 73% of death cases), cancer (14%), suicide (5%), pneumothorax (3%), cerebral infarction (3%) and acute myocardial infarction (3%). In the TB seq patients, 23 of 74 (31%) died during the observation period, 44 (59%) were alive, and the outcome was unknown in 7 (9%). The mean follow-up periodwas 53.9 ±24. 1 months (3.6-84.0 months). Fifty-seven TB seq patients (77%) received LTOTduring the observation period. The causes of death for the TB seq group were exacerbation of respiratory failure and related diseases such as right heart failure and pneumonia (18 patients; 78% of death cases), cancer (13%), acute myocardial infarction (4%) and others (4%). According to the conventional manner of analyzing mortality, patients whosecause of death had no relation with the background diseases were excluded. As a result, 27 COPD patients and 18 TB seq patients were included in the death group, and the other patients were treated as alive or discontinued at the end of the follow-up period. The cumulative survival rates by Kaplan-Meier method in both groups are shown in Fig. 1 . The overall survival rate of the COPDgroup was significantly lower than that of the TB seq group by the log-rank test (p<0.05).
Relationship between awake PaO2 and NOD
The sleep lowest SpO2 and the 85% desaturation time plotted against awake PaO2 in both groups are illustrated in Figs. 2 and 3, respectively. In the TB seq group the regression line between these two variables was located below that of the COPDgroup. In some of the TBseq patients with awake PaO2 over 60 mmHg,the sleep lowest SpO2values were unexpectedly lower than those expected from the awake PaO2in COPD patients. Whenthe variables were analyzed for the whole group including both dead and alive patients, the rates of the TB seq patients whose lowest SpO2 was 70% or less in the subgroups of 55<PaO2<60 mmHg and 55<PaO2<70 mmHgwere 46% (6 of 13 cases) and 36% (14 of 39 cases), respectively.
Similarly, the rates of the TB seq patients whose 85% desaturation time was greater than 60 minutes in 55<PaO2<60 mmHg and 55<PaO2<70 mmHgwere 39% (5 of 13 cases) and 33% Awake PaCte (mniHg) Awake PaCh (mmHg) Figure 2 . The sleep lowest SpO2 plotted against awake PaO2 in COPDpatients (left) and TB seq patients (right). In the TBseq group the regression line between these two variables was located below that in the COPDgroup. Vertical lines at awake PaO2 of 55 mmHgand 60 mmHg correspond to the levels of the guidelines for prescribing LTOTin patients with chronic respiratory failure issued by the Japan Society of Chest Diseases, i.e., PaO2 <55 mmHg in room air at rest, and 55 <PaO2 <60 mmHgin room air at rest associated with severe hypoxemia during exercise or sleep. Awake PaCh (mmHg) Awake PaCh (mmHg) Figure 3 . The total time spent with SpO2 of less than 85%(85% desaturation time) plotted against awake PaO2 in COPDpatients (left) and TB seq patients (right). Closed circles: death cases; open cirlces: alive patients and discontinued patients at the end of follow-up.
39 cases), respectively. On the other hand, the rates of COPD patients whose lowest SpO2 was 70%or less in the subgroups of 55<PaO2<60 mmHg and 55<PaO2<70 mmHgwere 25% (3 of 12 cases) and 14% (5 of37 cases), respectively. Similarly, the rates of COPDpatients whose 85%desaturation time was greater than 60 minutes in 55<PaO2<60 mmHgand 55<PaO2<70 mmHgwere 33% (4 of 12 cases) and 14% (5 of 37 cases), respectively. Moreover, it was observed that the mortality rate among the COPDpatients with lower sleep nadir SpO2 than predicted from the regression line was relatively high (arrows in Fig. 2 ).
Cox's proportional hazards analysis Cox' s proportional hazards model was used to demonstrate the prognostic factors independent of variables as well as of observation periods (Table 3 ). The data indicate that the sleep lowest SpO2 in COPD(p=0.0041) and the 85% desaturation time in TB seq (p=0.0022) were remarkably related to mortality. The sleep lowest SpO2was also weakly related to mortality in TB seq (p<0.05). However, no significant prognostic factor was observed in %VC, FEVL0%and PaCO2. 
Discussion
In the present study wedemonstrated the following points: 1) NODis one of the independent prognostic factors in both COPDand TB seq patients. 2) Sleep lowest SpO2 is a general and relevant factor for prognostic indication in both patient groups, and this was especially true in the COPDgroup.
3) The 85%desaturation time is a reliable prognostic factor in TB seq patients. In this study, the effect ofLTOT on survival rate could not be individually evaluated because almost all institutions started LTOTregardless of the value of daytime PaO2. As the usefulness ofLTOT has already been well established in patients with chronic respiratory failure, it cannot be justified to set up a control group without LTOT.The rates of association ofLTOT were very similar in both patient groups: 76% in COPDand 77%in TBseq. To eliminate the influence of with or without LTOTon the present analysis, we applied Cox's proportional hazards modelalso to the subgroups of patients whoreceived LTOTduring their follow-ups. The data demonstrated that the sleep lowest SpO2 in COPD(p=0.00 19) and the 85% desaturation time in TB seq (p=0.0061) were also remarkably related to mortality. From these findings, we assumed that LTOTmay essentially not have affected the results of the present analysis of survival rate. Hypoxemia during sleep may be caused by several physiological as well as pathological changes. It is conceivable that sleep oxyhemoglobin desaturation occurs mainly in association with the deterioration of ventilatory output which may be related to state-specific change, i.e., the differences among wakefulness, non-rapid eye movement (NREM)sleep and REMsleep (9, 10). Induced hypoventilation is known to be most severe during REMsleep, especially at the time of the appearance of bursts of eye movement,as comparedwith that during NREMsleep in normal subjects (ll, 12) as well as in patients with COPD(8, 9, 13) . In addition to sleep-related hypoventilation, several additional factors seem to play a role in inducing hypoxemia. It is generally known that, in COPD patients, the dead space is increased even during wakefulness.
In such a condition, oxyhemoglobindesaturation would be more clearly elicited in association with the change in breathing pattern such as rapid shallow breathing in REMsleep (9, 14) . REM-associated hypopnea also contributes to hypoxemia in such patients. Also, the impairment of ventilation-per fusion mismatching mainly due to the reduction in functional residual capacity possibly contributes to sleep-related hypoxemiain COPD patients (7). Moreover, the loss of intercostal and accessory muscle activity during REMsleep may cause a decrease in lung volume which is likely to be related to airway closure, resulting in the developmentof units with little ventilation in relation to their per fusion (9). Thus, there is evidence that hypoventilation contributes to sleep hypoxemia in COPD, and this may be accentuated by changes in the distribution of ventilation and perfusion in the lung.
On the other hand, in patients with TB seq, alveolar hypoventilation can easily occur due to other reasons during sleep. Lung compliance decreases because of pleural thickening and postiniiammatory pulmonary fibrosis, and also because of the loss of lung volume frequently caused by thoracoplasty inTB seqpatients (15, 16). The increaseinPaCO2has alsobeen reported to contribute to oxyhemoglobindesaturation during sleep through the right-downward shift of the oxyhemoglobin dissociation curve in such patients (6, 17) . Their ventilation can be maintained with the recruitment of accessory muscles including the external intercostal muscles so as to avoid the increase in PaCO2during wakefulness. Hypoventilation can be easily and predominantly produced during REMsleep in such patients, as the intercostal muscles are selectively suppressed compared with the diaphragm, resulting in severe hypoxemia during sleep. Different contributions by the mechanisms which cause NOD might explain someof the dissimilar relationships between NODand mortality in the COPDand TB seq patients. Sakumaet al (6) have reported that the magnitude of NOD was less profound in COPDpatients than in TB seq patients even though they had the same levels of awake PaO2. Nevertheless, the survival rate of COPDpatients was significantly lower when the subjects were chosen independently of awake PaO2 in the present study. At the same time, it was clearly demonstrated that the sleep lowest SpO2 is an important prognostic factor especially in COPDpatients. Our findings suggest that we must pay more attention to the possibility of COPDpatients having severe nadir SpO2 during sleep, and that this might have to be considered an indication for LTOT. As repetitive episodes of transient hypoxemiaduring sleep are knownto cause an increase in pulmonary vascular resistance (3, (18) (19) (20) , it is likely that the difference in mortality is derived from differences in the level of pulmonary artery pressure and/or pulmonary vascular resistance. The present study was performed by analyzing factors mainly related to physiological findings including pulmonary functions and diurnal and nocturnal hypoxemia. Due to the limited information from the registration cards, we could not investigate the effects of dyspnea, nutritional status and smoking, which are important known factors affecting survival. The possibility that they also contribute to the prognostic factors in COPDand TBseq patients must be recognized. In summary, the present study suggests that NODcan be an independent prognostic factor in both COPD and TB seq patients. This was especially the case when evaluated in terms of the sleep lowest SpO2 in COPDand the 85% desaturation time in TB seq. Observation of sleep oxyhemoglobin desaturation in these patients is clearly important from the viewpoint oflongterm outcome
